Are barbiturates contraindicated in patients receiving methadone?

Barbiturates and Methadone: Not Absolutely Contraindicated, But Extremely High Risk

Barbiturates are not absolutely contraindicated with methadone, but their concurrent use creates life-threatening risks through additive CNS/respiratory depression and accelerated methadone metabolism, requiring extreme caution and close monitoring if use cannot be avoided.

Critical Safety Concerns

Additive CNS and Respiratory Depression

The most immediate danger is additive depressant effects on the CNS and respiratory system when barbiturates are combined with opiates like methadone 1. This combination makes overdose "even more dangerous" and significantly increases mortality risk 1.

The FDA methadone label explicitly warns that patients receiving CNS depressants concomitantly with methadone may experience respiratory depression, hypotension, profound sedation, or coma 2. While the label specifically mentions "alcohol, other opioids, or illicit drugs," the principle applies equally to barbiturates given their mechanism of action.

Accelerated Methadone Metabolism

Barbiturates are well-known inducers of the hepatic cytochrome P450 (CYP) enzyme system and increase the metabolic clearance of CYP substrates 1. This creates a second critical problem:

• Phenobarbital can accelerate methadone biotransformation, leading to decreased plasma methadone levels 3
• This can precipitate opioid withdrawal symptoms in patients on methadone maintenance 3
• The interaction risks delayed opioid withdrawal and relapse when administered concurrently 4

One case report documented a methadone maintenance patient who experienced withdrawal symptoms due to phenobarbital-induced acceleration of methadone metabolism, requiring plasma methadone level monitoring 3.

Clinical Decision Algorithm

If Barbiturate Use is Being Considered:

1. First, determine if barbiturate is truly necessary - Most indications (anxiety, insomnia) have safer alternatives

2. For alcohol withdrawal specifically: Recent evidence shows phenobarbital is effective 5, but in patients with concurrent opioid use disorder on methadone, safeguards should be in place to avoid phenobarbital in most cases 4

3. If barbiturate cannot be avoided:

   • Do not stop methadone abruptly - the perioperative guideline states butalbital should not be stopped abruptly if used long-term to avoid acute withdrawal 6
   • Monitor plasma methadone levels when phenobarbital is used with methadone 3
   • Increase methadone dose as needed to compensate for accelerated metabolism
   • Monitor respiratory status continuously - have naloxone immediately available 2
   • Watch for signs of withdrawal: restlessness, lacrimation, rhinorrhea, yawning, perspiration, chills, myalgia 2

Key Monitoring Parameters:

• Respiratory rate and depth - barbiturates suppress the medullary respiratory center 1
• Level of consciousness - watch for profound sedation
• Blood pressure - risk of hypotension with combined use 2
• Plasma methadone concentration - particularly with phenobarbital 3
• Withdrawal symptoms - if methadone levels drop

Special Populations at Higher Risk

The combination is particularly dangerous in:

• Elderly or debilitated patients 2
• Patients with COPD or respiratory compromise - even therapeutic barbiturate doses may dangerously decrease pulmonary ventilation 1
• Patients with congestive heart failure - more vulnerable to cardiovascular depression 1
• Patients on high methadone doses - greater risk of respiratory depression

Common Pitfalls to Avoid

1. Assuming tolerance protects against respiratory depression - while tolerance develops to sedative effects, tolerance to lethal respiratory depression does NOT develop 1

2. Abruptly stopping either medication - risks withdrawal from methadone or barbiturates 6, 2

3. Failing to adjust methadone dose when barbiturate is added - the accelerated metabolism will lower methadone levels 3

4. Using mixed agonist-antagonist opioids (pentazocine, nalbuphine, butorphanol) in patients on methadone - these will precipitate acute withdrawal 7

Bottom Line for Clinical Practice

While not an absolute contraindication, the combination should be avoided whenever possible. If unavoidable, treat this as a high-risk situation requiring:

• Intensive monitoring
• Plasma methadone level checks
• Methadone dose adjustments
• Immediate access to naloxone
• Continuous respiratory monitoring

For patients with opioid use disorder on methadone maintenance therapy, alternative agents to barbiturates should be strongly preferred 4.